Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.20M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$824K$1.6M2017 · bought $239K · sold $020172020 · bought $100K · sold $020202026 · bought $1.6M · sold $02026
Total +$1.99M bought

All filings on record

Every Form 4 transaction we track for this filer

IDYABuy
2026-03-02 · IDEAYA Biosciences, Inc.
$1.65M
in progress
CDTXReturn
2026-01-07 · Cidara Therapeutics, Inc.
$14.95M
CDTXReturn
2026-01-07 · Cidara Therapeutics, Inc.
$526.9K
CDTXReturn
2026-01-07 · Cidara Therapeutics, Inc.
$1.28M
CDTXGift
2025-12-22 · Cidara Therapeutics, Inc.
5,425
CDTXGift
2025-12-19 · Cidara Therapeutics, Inc.
10,638
CDTXGift
2025-12-19 · Cidara Therapeutics, Inc.
10,638
CDTXGift
2025-12-17 · Cidara Therapeutics, Inc.
2,244
CDTXGift
2025-12-17 · Cidara Therapeutics, Inc.
2,244
CDTXGift
2025-12-10 · Cidara Therapeutics, Inc.
33,072
CDTXGift
2025-12-10 · Cidara Therapeutics, Inc.
33,072
CDTXTax
2025-12-10 · Cidara Therapeutics, Inc.
$501.8K
CDTXGift
2021-12-31 · Cidara Therapeutics, Inc.
937
CDTXGift
2021-12-31 · Cidara Therapeutics, Inc.
1,873
CDTXOther
2020-12-10 · Cidara Therapeutics, Inc.
658
CDTXBuy
2020-11-10 · Cidara Therapeutics, Inc.
$100.0K
CDTXOther
2020-11-10 · Cidara Therapeutics, Inc.
$100.0K
CDTXBuy
2017-09-12 · Cidara Therapeutics, Inc.
$49.8K
CDTXOther
2017-09-12 · Cidara Therapeutics, Inc.
$49.8K
CDTXBuy
2017-06-05 · Cidara Therapeutics, Inc.
$89.2K
CDTXOther
2017-06-05 · Cidara Therapeutics, Inc.
$89.2K
CDTXBuy
2017-03-31 · Cidara Therapeutics, Inc.
$100.0K
CDTXOther
2017-03-31 · Cidara Therapeutics, Inc.
$100.0K
CDTXOther
2016-05-23 · Cidara Therapeutics, Inc.
270

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.